| Syncom Formulations (India) Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524470 |
NSE Symbol : SYNCOMF |
P/E(TTM) : 22.42 |
|
ISIN Demat : INE312C01025 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.67 |
|
Book Value(₹) : 4.00 |
Market Cap(₹Cr) : 1,411.88 |
Face Value(₹) : 1.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 121.44 | 116.55 | 148.46 | 127.03 | 101.49 | 86.83 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 121.44 | 116.55 | 148.46 | 127.03 | 101.49 | 86.83 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 5.23 | 6.06 | 6.91 | 3.82 | 4.18 | 1.31 |
| Total Income | 126.67 | 122.61 | 155.37 | 130.85 | 105.68 | 88.14 |
| Total Expenditure | 102.71 | 100.77 | 130.99 | 112.43 | 89.57 | 76.36 |
| PBIDT | 23.96 | 21.84 | 24.38 | 18.42 | 16.11 | 11.78 |
| Interest | 0.25 | 0.24 | 0.09 | 0.21 | 0.16 | 0.39 |
| PBDT | 23.71 | 21.60 | 24.29 | 18.21 | 15.95 | 11.40 |
| Depreciation | 1.35 | 1.34 | 1.29 | 1.31 | 1.30 | 1.30 |
| Tax | 5.22 | 4.32 | 4.50 | 4.03 | 3.49 | 2.44 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.30 | 0.21 | 1.00 | 0.09 | 0.21 | 0.03 |
| Reported Profit After Tax | 16.84 | 15.73 | 17.50 | 12.79 | 10.95 | 7.63 |
| Extra-ordinary Items | 0.00 | 0.03 | 0.01 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 16.84 | 15.70 | 17.49 | 12.79 | 10.95 | 7.63 |
| EPS (Unit Curr.) | 0.18 | 0.21 | 0.16 | 0.14 | 0.16 | 0.11 |
| EPS (Adj) (Unit Curr.) | 0.18 | 0.21 | 0.16 | 0.14 | 0.16 | 0.11 |
| Calculated EPS (Unit Curr.) | 0.18 | 0.17 | 0.19 | 0.14 | 0.12 | 0.08 |
| Calculated EPS (Adj) (Unit Curr.) | 0.18 | 0.17 | 0.19 | 0.14 | 0.12 | 0.08 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.72 | 0.67 | 0.74 | 0.54 | 0.47 | 0.32 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.72 | 0.67 | 0.74 | 0.54 | 0.47 | 0.32 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 94.00 | 94.00 | 94.00 | 94.00 | 94.00 | 94.00 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 19.73 | 18.74 | 16.42 | 14.50 | 15.87 | 13.57 |
| PBDTM(%) | 19.52 | 18.53 | 16.36 | 14.34 | 15.72 | 13.13 |
| PATM(%) | 13.87 | 13.50 | 11.79 | 10.07 | 10.79 | 8.79 |